ABSTRACT G(IIKK) 3 I-NH 2 (G3) has been recently shown to be highly effective at killing bacteria and inhibiting tumor cell growth while remaining benign to normal host mammalian cells.
INTRODUCTION
With human cancer remaining a cause of high morbidity and mortality worldwide, novel, selective and more efficient drugs and treatments are urgently needed. Recent studies have reported the effective inhibition of cancer cell growth by amphipathic antimicrobial peptides (AMPs) via selectively disrupting cell membranes. [1] [2] [3] [4] AMPs that also show anticancer activities are called anticancer peptides (ACPs). Although ACPs exhibit many desirable properties such as broad spectrum activity, high structural stability and low probability of inducing resistance, [3] [4] [5] their development as novel anticancer agents is hampered by their poor bioavailability, potential immunogenicity, cytotoxicity to host cells and high production costs. 4, 6 To circumvent these problems, researchers have tried to develop novel synthetic ACPs, e.g., by sequence modifications from naturally occurring template peptides, 2, 7 by D-amino acid substitution at the nonpolar surface, 8, 9 and by shortening peptide sequences to reduce cost. 1, 10, 11 In the course of structural design for optimal ACPs, properties including sequence, length, net charge, secondary structure, amphipathicity and hydrophobicity must be carefully examined. 1, [4] [5] 12 The outer membrane surfaces of cancer cells are negatively charged and it is widely thought that cell death mediated by membrane-lytic ACPs starts with peptide binding to the outer membranes of tumor cells via electrostatic interactions between the positive charges of the peptides and the negatively charged groups on the outer membrane surfaces of cancer cells. 2, [5] [6] Therefore, ACPs with net positive charges possess high affinity to cancer cells, leading to their rapid binding to cancer cell membranes. Upon membrane binding, hydrophobic interactions between peptides and membrane lipids would become dominant, and this process is strengthened by the conformational transition of ACPs (e.g., from disordered to helical transition) and the consequent formation of amphipathic structures, which would favor their insertion and self-association within the membrane core, as well as their translocation into the inner face of the lipid membrane, finally becoming internalized. 2, [4] [5] The overall hydrophobicity of a helical ACP relies on not only the hydrophobicity of its constituent amino acids but also its helical propensity pertinent to peptide sequence. 13 Increasing levels of hydrophobicity on the nonpolar face of a 26-residue α-helical peptide (peptide P:
Ac-KWKSFLKTFKSAKKTVLHTALKAISS-amide) enhanced peptide helicity and self-association ability, leading to higher anticancer activity but stronger hemolytic activity. 14 To improve the cell specificity or therapeutic index of this peptide and its analogues, D-amino acids were introduced into the nonpolar face to modulate peptide hydrophobicity and helicity. 15 Additionally, simple terminal modifications including N-terminal acetylation, C-terminal amidation, end-tagging and single amino acid substitutions have also been employed to alter the properties of AMPs and ACPs, with some of these peptide variants showing enhanced antibacterial and anticancer activity and cell selectivity. [16] [17] [18] Furthermore, previous studies have also suggested that end capping and cyclization of hexameric peptide sequences of RRWQWR and RRWWRF or end-tagging of short peptides KNK10 (KNKGKKNGKH) and GKH17
(GKHKNKGKKNGKHNGWK) with hydrophobic Trp (W) or Phe (F) stretches could alter the susceptibility of AMPs to proteolytic degradation, thereby enhancing their stability in serum. [19] [20] [21] Hence, terminal modifications could be a useful strategy for enhancing AMP and ACP's stability against proteolytic degradation. However, the influence of terminal modifications on the anticancer activity and cell selectivity of ACPs
has not yet been understood well.
We have previously designed a serial of antitumor peptides, G(IIKK) n I-NH 2 (n=2-4), based on the common features of naturally occurring AMPs, i.e. amphiphilicity and cationicity. [22] [23] Among this serial of peptides, G(IIKK) 3 I-NH 2 was found to display high selectivity between tumor cells and normal mammalian host cells following the extensive examination of peptide length, net positive charges, helicity and hydrophobicity. Our recent study has indicated that whilst deleting its terminal amino acids had little impact on their antibacterial behavior, their antitumor activity declined sharply. 25 To make a more systematic investigation of the effects of terminal modifications, we have synthesized 2 groups of peptides through single amino acid substitutions at the N-terminus or C-terminus with hydrophobic amino acids (Ala or Val), positively charged amino acid (Lys), and negatively charged polar amino acid (Glu). The physicochemical properties of these peptides including their hydrophobicity, secondary structures and surface activity were assessed. Their bioactivity including antitumor activity and cytotoxicity to normal host cells was also examined. The results indicated that N-and C-terminal modifications could affect their physiochemical properties and bioactivity very differently. The surface activity of the peptides, quantified by surface pressure upon adsorption at the air/water interface, controlled their antitumor activity. However, the hydrophobicity of the peptides, quantified by retention times in reversed phase high performance liquid chromatograph (RP-HPLC), dictated their hemolytic activity.
Maintenance of a relatively high surface pressure and attainment of decreased hydrophobicity from a single amino acid substitution, e.g., at the N-terminus of G(IIKK) 3 I-NH 2 , can work as an efficient strategy to decrease cytotoxicity to mammalian host cells whilst retaining potent antitumor activity. DPPC and DPPG SUVs were prepared by ultrasonic treatment as described previously. 
EXPERIMETNAL SECTION

RESULTS AND DISCUSSION
Peptide Design and Their Physiochemical Properties
G(IIKK) 3 I-NH 2 (G3) is a leading peptide identified from a list of designed AMPs that have been extensively studied in our previous work. It shows potent antibacterial and antitumor activity and low cytotoxicity to normal host mammalian cells. [22] [23] [24] Furthermore, deleting the N-terminal Gly residue and/or the C-terminal Ile residue in G3 can alter antitumor activity. 24 As an effective strategy to stabilize helical structures in proteins, however, specific N-and C-capping motifs are widely exercised in many biological areas, 25, 26 resulting in different bioactivities. Interestingly, more than 70% of naturally occurring AMPs start with Gly residue in the N-terminus, which is thought to resist enzyme degradation. 7 To better understand the effects of the terminal modifications of G(IIKK) 3 I-NH 2 on antitumor activity and to develop new variants with enhanced cell selectivity, we have designed two series of new peptides containing different capping groups at both termini, as shown in Table 1 . Specifically, the N-terminal Gly or C-terminal Ile residue of G(IIKK) 3 I-NH 2 was replaced by 1) hydrophobic amino acids Ala and Val, both of which are more hydrophobic than Gly but less hydrophobic than Ile;
2) Glu, which contains a negative charge at its side chain, and 3) Lys, which adds one more positive charge at the N-terminus or C-terminus. The molecular masses of the synthesized peptides obtained from MALDI-TOF MS measurements were well consistent with their theoretical values, indicating that the products corresponded to the designed sequences (Table 1) . 1) The peptide sequences are presented with the one letter amino acid code.
2) The theoretical molecular masses were calculated based on a peptide property calculator (http://www.pepcalc.com/).
3) The measured molecular masses were determined from MODAL-TOF MS measurements, corresponding to the m/z values.
Peptide Hydrophobicity. Peptide hydrophobicity was assessed by using RP-HPLC, which measures hydrophobic interactions between peptides and the nonpolar surface of the reversed stationary phase (typically C18-derivatized), expressed as retention time.
Because of the broad similarity of the hydrophilic/hydrophobic interface provided by the chromatographic system to the cell membrane, the measured RP-HPLC retention times can be used as a useful implication of their hydrophobic interaction with the cell membrane. In addition to the hydrophobicity of each residue and peptide length, the retention time is also sensitive to the conformational state (e.g., amphipathicity and secondary structures) of peptides at the aqueous/C18 group interface. 28 The formation of an amphipathic helical structure usually results in stronger retention on the hydrophobic column matrix, presumably through a preferred hydrophobic binding domain, and the RP-HPLC retention times of some helical peptides were thus found to correlate well with their helicities in CD measurements. 13, [27] [28] [29] It can be seen from Table 1 However, the measured hydrophobicity of the N-terminal variants from RP-HPLC did not follow the hydrophobic order of individual amino acids (Table 1 Surface Property. Over 50% of the active ACPs are physically surface active, suggesting that amphipathicity is a key driver of the membrane interactions for these peptides. 4 As the air/water interface constitutes a useful model to investigate the interfacial affinity of peptides, 33, 34 we have compared the adsorption properties of the peptides at this interface. Helical Structure. CD was used to determine the secondary structures of the peptides.
In water, these peptides adopted random coil conformation, due to the considerable intermolecular hydrogen bonding between peptide backbones and water molecules and repulsive interaction between charged side chains. 26 This observation was similar to that of a smaller helical peptide K 0 -W 6 -Hy-al. 18 Similar to the surface pressure, the peptide helicity for the C-terminal variants also showed a marked variation with hydrophobicity ( Figure 3B ). However, their correlation was very weak, the helicities of all the C-terminal variants being significantly reduced 
Bioactivities
The This result suggests that the electrostatic interaction plays an essential role in enhancing antitumor activity. Although N-terminal Gly was widely considered to help stabilize peptides under serum conditions, 7 its substitution from G(IIKK) 3 I-NH 2 in this study did not cause any measurable peptide degradation in serum ( Figure S1 ).
In contrast, the antitumor activities of the C-terminal variants changed a lot ( Figure 5 a-d). In addition to G(IIKK) 3 Generally, the peptides with higher antitumor activities showed slightly higher toxicity to normal mammalian HCa cells (Figures 6A and 6a) . Relative to the reference peptide G(IIKK) 3 I-NH 2 that caused ~50% erythrocyte hemolysis at ~500 μΜ, the hemolytic activity of all the N-terminal variants was significantly decreased ( Figure 6B ). had little toxicity to HCa cells and did not cause any hemolysis at all, even at concentrations up to 500 μΜ (Figures 6a and 6b) . It has been reported that an uninterrupted sector of 5 hydrophobic residues of α-helical AMPs was sufficient for their good antimicrobial activity. 37, 38 Here, all the peptides in this study contain at least 5 undisrupted Ile residues (I 3 , I 6 , I 7 , I 10 , and I 11 ) in the hydrophobic surface and furthermore, their terminal residues are located on the ends of helical wheels (Figure 1 ). Their bioactivities, in particular for the C-terminal variants, were found to vary over a wide range, indicating that the exact bioactivities of the peptides may be influenced by other factors such as their hydrophobicity, surface pressure, and helicity. The above physical measurements indicated that N-and C-terminal modifications imposed marked impact on these factors, also in particular for the C-terminal variants, resulting in very different bioactivity. showed lower hemolytic activities ( Figure 7D ), their antitumor activities were significantly decreased due to their lower surface pressures ( Figure 7A ), causing reduction in cell selectivity.
Tumor Cell Membrane Disruption
As G(IIKK) 3 
CONCLUSIONS
To better understand the effects of terminal amino acid modifications on the physical properties and bioactivity of the designed peptides and explore the basic relationship between them, we have designed two groups of peptides by replacing the N-terminal Gly or C-terminal Ile residue with Ala, Val, Glu and Lys residues from an well studied 
